In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanotechnology - regulation needs to catch up

This article was originally published in Clinica

Executive Summary

As reported in Clinica this week (, 4 November), the US government is seeking feedback from the public on a draft of its 2010 National Nanotechnology Initiative (NNI) Strategic Plan, which includes a section on the FDA's priorities for the responsible development of nanomaterials in the products it regulates.

You may also be interested in...

Start-Up Spotlight: Protaryx Aims To Simplify Transseptal Access

The company formed by ex-Edwards Lifesciences exec and Harpoon Medical founder raised $8m in Series A for universal catheter system for delivering beating heart treatments.

UK Competition Watchdog Has Concerns About Stryker/Wright Medical Merger

The UK Competition and Markets Authority has concerns over the impact on the market for ankle replacements that would result from Stryker's planned $4bn acquisition of Wright Medical.

FDA Pulls Chembio’s Rapid Test As Purge Of ‘Inaccurate’ Antibody Tests Continues

Chembio’s stock opened down 60% the day after the FDA’s decision to revoke its EUA for the first US rapid test for antibodies to SARS-CoV-2.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts